|
2025-02-27 |
2025-02-25 |
V
Verkauf
|
AHMED NADIM
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
12.529
-2.8%
8,53
106.872 USD
|
12.529
-2.8%
|
8,53
|
106.872 USD
|
|
|
2025-02-27 |
2025-02-25 |
V
Verkauf
|
Jones Jeffrey Alan
Chief Medical Officer
Führungsperson
|
4.895
-2.7%
8,53
41.754 USD
|
4.895
-2.7%
|
8,53
|
41.754 USD
|
|
|
2025-02-27 |
2025-02-25 |
V
Verkauf
|
SUMER JACQUELYN L
Chief Legal Officer
Führungsperson
|
3.756
-2.7%
8,53
32.039 USD
|
3.756
-2.7%
|
8,53
|
32.039 USD
|
|
|
2025-02-27 |
2025-02-25 |
V
Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
3.756
-2.6%
8,53
32.039 USD
|
3.756
-2.6%
|
8,53
|
32.039 USD
|
|
|
2025-01-07 |
2025-01-06 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
4.000
-4.0%
12,51
50.040 USD
|
4.000
-4.0%
|
12,51
|
50.040 USD
|
|
|
2024-12-27 |
2024-12-24 |
V
Verkauf
|
AHMED NADIM
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
8.400
-3.1%
11,87
99.708 USD
|
8.400
-3.1%
|
11,87
|
99.708 USD
|
|
|
2024-12-20 |
2024-12-18 |
V
Verkauf
|
SUMER JACQUELYN L
Chief Legal Officer
Führungsperson
|
3.482
-3.7%
11,41
39.730 USD
|
3.482
-3.7%
|
11,41
|
39.730 USD
|
|
|
2024-12-20 |
2024-12-18 |
V
Verkauf
|
Jones Jeffrey Alan
Chief Medical Officer
Führungsperson
|
4.632
-3.9%
11,41
52.851 USD
|
4.632
-3.9%
|
11,41
|
52.851 USD
|
|
|
2024-12-20 |
2024-12-18 |
V
Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
4.693
-4.5%
11,41
53.547 USD
|
4.693
-4.5%
|
11,41
|
53.547 USD
|
|
|
2024-12-16 |
2024-12-12 |
V
Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
3.489
-3.2%
12,52
43.682 USD
|
3.489
-3.2%
|
12,52
|
43.682 USD
|
|
|
2024-11-07 |
2024-11-05 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
8.000
-6.9%
15,64
125.120 USD
|
8.000
-6.9%
|
15,64
|
125.120 USD
|
|
|
2024-09-09 |
2024-09-05 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
8.000
-6.5%
18,09
144.720 USD
|
8.000
-6.5%
|
18,09
|
144.720 USD
|
|
|
2024-07-09 |
2024-07-05 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
8.000
-6.1%
16,33
130.640 USD
|
8.000
-6.1%
|
16,33
|
130.640 USD
|
|
|
2024-05-08 |
2024-05-07 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
5.606
-4.1%
30,06
168.516 USD
|
5.606
-4.1%
|
30,06
|
168.516 USD
|
|
|
2024-05-08 |
2024-05-06 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
20.277
-13.5%
28,54
578.706 USD
|
20.277
-13.5%
|
28,54
|
578.706 USD
|
|
|
2024-05-08 |
2024-05-06 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
37.723
-20.1%
27,82
1.049.454 USD
|
37.723
-20.1%
|
27,82
|
1.049.454 USD
|
|
|
2024-02-02 |
2024-02-01 |
GV
Geplanter Verkauf
|
Savill Corrine
Chief Business Officer
Führungsperson
|
40.000
-19.4%
16,18
647.200 USD
|
40.000
-19.4%
|
16,18
|
647.200 USD
|
|
|
2024-01-30 |
2024-01-29 |
GV
Geplanter Verkauf
|
Savill Corrine
Chief Business Officer
Führungsperson
|
40.000
-19.4%
14,09
563.600 USD
|
40.000
-19.4%
|
14,09
|
563.600 USD
|
|
|
2024-01-24 |
2024-01-23 |
GV
Geplanter Verkauf
|
Savill Corrine
Chief Business Officer
Führungsperson
|
21.316
-11.4%
12,46
265.597 USD
|
21.316
-11.4%
|
12,46
|
265.597 USD
|
|
|
2024-01-24 |
2024-01-22 |
GV
Geplanter Verkauf
|
Savill Corrine
Chief Business Officer
Führungsperson
|
4.125
-2.4%
12,02
49.583 USD
|
4.125
-2.4%
|
12,02
|
49.583 USD
|
|
